Showing results (211-220 of 379) with videos related to
Sort By:
Pageof 38
Annals of the Rheumatic Diseases|July 24, 2004
When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?M Dougados, P Emery, E M Lemmel, et al.Rheumatology (Oxford, England)|May 18, 1999
Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trialM Dougados, A Gueguen, J P Nakache, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 1, 1995
Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitoninC Roux, C Pelissier, V Listrat, et al.La Nouvelle Presse Medicale|September 20, 1980
[Treatment of severe systemic lupus erythematosus. Long-term results in 55 patients (author's transl)]P Jungers, M Dougados, F Tron, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 15, 2007
Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patientS Guignard, D Hubert, B Dupont, et al.Annals of the Rheumatic Diseases|June 17, 2005
Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?A Wanders, R Landewé, M Dougados, et al.Annals of the Rheumatic Diseases|August 13, 2005
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitisJ Braun, J Davis, M Dougados, et al.Scandinavian Journal of Rheumatology|January 1, 1994
Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging studyM Dougados, M Nguyen, R Caporal, et al.Annals of the Rheumatic Diseases|March 5, 2002
Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guideP Emery, F C Breedveld, M Dougados, et al.Clinical and Experimental Immunology|September 1, 1984
The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosusP S Mach, M Kharouby, F Lutcher, et al.Pageof 38